Submission for OMB Review; Comment Request; Patent Term Extension, 5636 [2020-01849]
Download as PDF
5636
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
information collection should be sent on
or before March 2, 2020 to Nicholas A.
Fraser, OMB Desk Officer, via email to
Nicholas_A._Fraser@omb.eop.gov, or by
fax to 202–395–5167, marked to the
attention of Nicholas A. Fraser.
Marcie Lovett,
Chief, Records and Information Governance
Branch, Office of the Chief Administrative
Officer, Office of Administrative Services,
Strategic and Data Transport Division, United
States Patent and Trademark Office.
[FR Doc. 2020–01851 Filed 1–30–20; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
jbell on DSKJLSW7X2PROD with NOTICES
Submission for OMB Review;
Comment Request; Patent Term
Extension
The United States Patent and
Trademark Office (USPTO) will submit
to the Office of Management and Budget
(OMB) for clearance the following
proposal for an information collection
under the provisions of the Paperwork
Reduction Act of 1995.
Agency: United States Patent and
Trademark Office, Department of
Commerce.
Title: Patent Term Extension.
OMB Control Number: 0651–0020.
Form Number(s): There are no forms
in this information collection.
Type of Request: Revision of a
currently approved information
collection.
Number of Respondents: 620
respondents.
Average Hours per Response: The
USPTO estimates that it will take the
public from 1 hour to 25 hours to gather
the necessary information, prepare the
appropriate form or document, and
submit the information to the USPTO.
Burden Hours: 4,102 hours.
Hourly Cost Burden: $1,796,676.
Non Hourly Cost Burden: $209,889.
Needs and Uses: The patent term
restoration portion of the Drug Price
Competition and Patent Term
Restoration Act of 1984 (Pub. L. 98–
417), which is codified at 35 U.S.C. 156,
permits the United States Patent and
Trademark Office (USPTO) to extend
the term of protection under a patent to
compensate for delay during regulatory
review and approval by the Food and
Drug Administration (FDA) or United
States Department of Agriculture
(USDA). Only patents for drug products,
medical devices, food additives, or color
additives are potentially eligible for
extension. The maximum length that a
patent may be extended under 35 U.S.C.
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
156 is 5 years. The USPTO administers
35 U.S.C. 156 through 37 CFR 1.710–
1.791. Separate from the extension
provisions of 35 U.S.C. 156, the USPTO
may in some cases extend the term of an
original patent due to certain delays in
the prosecution of the patent
application, including delays caused by
interference proceedings, secrecy
orders, or appellate review by the Patent
Trial and Appeal Board or a Federal
court in which the patent is issued
pursuant to a decision reversing an
adverse determination of patentability.
The patent term provisions of 35 U.S.C.
154(b), as amended by Title IV, Subtitle
D of the Intellectual Property and
Communications Omnibus Reform Act
of 1999, require the USPTO to notify the
applicant of the patent term adjustment
in the notice of allowance and give the
applicant an opportunity to request
reconsideration of the USPTO’s patent
term adjustment determination.
The public uses this information
collection to file requests related to
patent term extensions and
reconsideration or reinstatement of
patent term adjustments. The
information in this information
collection is used by the USPTO to
consider whether an applicant is
eligible for a patent term extension or
reconsideration of a patent term
adjustment and, if so, to determine the
length of the patent term extension or
adjustment.
Affected Public: Businesses or other
for-profits; not-for-profit institutions.
Frequency: On occasion.
Respondent’s Obligation: Required to
obtain or retain benefits.
OMB Desk Officer: Nicholas A. Fraser,
email: Nicholas_A._Fraser@
omb.eop.gov. Once submitted, the
request will be publicly available in
electronic format through reginfo.gov.
Follow the instructions to view
Department of Commerce information
collections currently under review by
OMB.
Further information can be obtained
by:
• Email: InformationCollection@
uspto.gov. Include ‘‘0651–0020
information request’’ in the subject line
of the message.
• Mail: Kimberly Hardy, Office of the
Chief Administrative Officer, United
States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313–
1450.
Written comments and
recommendations for the proposed
information collection should be sent on
or before March 2, 2020 to Nicholas A.
Fraser, OMB Desk Officer, via email to
Nicholas_A._Fraser@omb.eop.gov, or by
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
fax to 202–395–5167, marked to the
attention of Nicholas A. Fraser.
Marcie Lovett,
Chief, Records and Information Governance
Branch, Office of the Chief Administrative
Officer, Office of Administrative Services,
Strategic and Data Transport Division.
[FR Doc. 2020–01849 Filed 1–30–20; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Submission for OMB Review;
Comment Request; Deposit of
Biological Materials
The United States Patent and
Trademark Office (USPTO) will submit
to the Office of Management and Budget
(OMB) for clearance the following
proposal for collection of information
under the provisions of the Paperwork
Reduction Act of 1995.
Agency: United States Patent and
Trademark Office, Department of
Commerce.
Title: Deposit of Biological Materials.
OMB Control Number: 0651–0022.
Form Number(s): There are no forms
in this information collection.
Type of Request: Revision of a
currently approved information
collection.
Number of Respondents: 951
respondents.
Average Hours per Response: The
USPTO estimates that it will take the
public 1 hour to gather the necessary
information, prepare the appropriate
documents, and submit the information
to the USPTO for a deposit of biological
materials. The USPTO estimates that it
will take 5 hours to collect and submit
the information required to become a
depository.
Burden Hours: 955 hours.
Hourly Cost Burden: $42,914.
Annual (non-hourly) Cost: $2,823,237.
Needs and Uses: Information on the
deposit of biological materials in
depositories is required for (a) the
USPTO determination of compliance
with 35 U.S.C. 2(b)(2) and 112, and 37
CFR 1.801–1.809 and 1.14, where
inventions sought to be patented rely on
biological material subject to the deposit
requirement, including notification to
the interested public about where to
obtain samples of deposits; and (b) in
compliance with 37 CFR 1.803 to
demonstrate that the depositories are
qualified to store and test the biological
material submitted to them. This
information collection is used by the
USPTO to determine whether or not the
applicant has met the requirements of
E:\FR\FM\31JAN1.SGM
31JAN1
Agencies
[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Page 5636]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01849]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Submission for OMB Review; Comment Request; Patent Term Extension
The United States Patent and Trademark Office (USPTO) will submit
to the Office of Management and Budget (OMB) for clearance the
following proposal for an information collection under the provisions
of the Paperwork Reduction Act of 1995.
Agency: United States Patent and Trademark Office, Department of
Commerce.
Title: Patent Term Extension.
OMB Control Number: 0651-0020.
Form Number(s): There are no forms in this information collection.
Type of Request: Revision of a currently approved information
collection.
Number of Respondents: 620 respondents.
Average Hours per Response: The USPTO estimates that it will take
the public from 1 hour to 25 hours to gather the necessary information,
prepare the appropriate form or document, and submit the information to
the USPTO.
Burden Hours: 4,102 hours.
Hourly Cost Burden: $1,796,676.
Non Hourly Cost Burden: $209,889.
Needs and Uses: The patent term restoration portion of the Drug
Price Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-
417), which is codified at 35 U.S.C. 156, permits the United States
Patent and Trademark Office (USPTO) to extend the term of protection
under a patent to compensate for delay during regulatory review and
approval by the Food and Drug Administration (FDA) or United States
Department of Agriculture (USDA). Only patents for drug products,
medical devices, food additives, or color additives are potentially
eligible for extension. The maximum length that a patent may be
extended under 35 U.S.C. 156 is 5 years. The USPTO administers 35
U.S.C. 156 through 37 CFR 1.710-1.791. Separate from the extension
provisions of 35 U.S.C. 156, the USPTO may in some cases extend the
term of an original patent due to certain delays in the prosecution of
the patent application, including delays caused by interference
proceedings, secrecy orders, or appellate review by the Patent Trial
and Appeal Board or a Federal court in which the patent is issued
pursuant to a decision reversing an adverse determination of
patentability. The patent term provisions of 35 U.S.C. 154(b), as
amended by Title IV, Subtitle D of the Intellectual Property and
Communications Omnibus Reform Act of 1999, require the USPTO to notify
the applicant of the patent term adjustment in the notice of allowance
and give the applicant an opportunity to request reconsideration of the
USPTO's patent term adjustment determination.
The public uses this information collection to file requests
related to patent term extensions and reconsideration or reinstatement
of patent term adjustments. The information in this information
collection is used by the USPTO to consider whether an applicant is
eligible for a patent term extension or reconsideration of a patent
term adjustment and, if so, to determine the length of the patent term
extension or adjustment.
Affected Public: Businesses or other for-profits; not-for-profit
institutions.
Frequency: On occasion.
Respondent's Obligation: Required to obtain or retain benefits.
OMB Desk Officer: Nicholas A. Fraser, email:
[email protected]. Once submitted, the request will be
publicly available in electronic format through reginfo.gov. Follow the
instructions to view Department of Commerce information collections
currently under review by OMB.
Further information can be obtained by:
Email: [email protected]. Include ``0651-
0020 information request'' in the subject line of the message.
Mail: Kimberly Hardy, Office of the Chief Administrative
Officer, United States Patent and Trademark Office, P.O. Box 1450,
Alexandria, VA 22313-1450.
Written comments and recommendations for the proposed information
collection should be sent on or before March 2, 2020 to Nicholas A.
Fraser, OMB Desk Officer, via email to [email protected],
or by fax to 202-395-5167, marked to the attention of Nicholas A.
Fraser.
Marcie Lovett,
Chief, Records and Information Governance Branch, Office of the Chief
Administrative Officer, Office of Administrative Services, Strategic
and Data Transport Division.
[FR Doc. 2020-01849 Filed 1-30-20; 8:45 am]
BILLING CODE 3510-16-P